ATRAのPER（株価収益率）は？

Atara Biotherapeutics Inc（ATRA）は現在PER 32.27倍で取引されています。

ATRAのROE（自己資本利益率）は？

Atara Biotherapeutics IncのROEは25.37%です。

ATRAの配当利回りは？

Atara Biotherapeutics Incの配当利回りは0.00%です。

ATRAの品質スコア（Quality Score）は？

当社のAIはATRAの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

ATRAは今が買い時ですか？

当社AIのタイミングスコアは100点中30点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

ATRAはどのセクターに属しますか？

Atara Biotherapeutics IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

ATRA (NASDAQ) 株価分析 | ATARA BIOTHERAPEUTICS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

ATRA AI Analysis Summary

Our AI summary for ATRA: Atara Biotherapeutics Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 32.27, ROE of 25.37%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 30/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ATRA

Atara Biotherapeutics Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 87

USD 8.77

0.22 (2.57%) Day Change

Watchlist Portfolio Compare Chart

32.27

P/E

-0.03

D/E

25.4%

ROE

-47.3%

ROA

0.00%

Div Yield

-0.51

PEG

ATARA BIOTHERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 8.77 Price 0.22 (2.57%) Day Change	NEWS SCORE: 87

ATRA, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	87
Magic Formula Rank by ROA	850
Magic Formula Rank by ROE	850
Magic Formula Rank by ROIC	824
Price	8.77
PBV / Sector	-2.06 / 44,022.72
Earning Per Share	-1.08

PE / Sector	32.27 / 19.17
PEG or PE/Growth / Sector	-0.51 / 1.24
Average 1M Daily Value	0.65 M GREAT
Average 1W Daily Value	0.44 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-40.91 / 98.24
NPM Average (%) / Sector	-732.02 / -1,697.63
NPM Change Average (%) / Sector	76.73 / 5,097.97 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-47.34 / 185,260.96
ROA Average (%) / Sector	-38.31 / 36,684.70
ROA Change Average (%) / Sector	-78.42 / 422,221.66
ROE (%) / Sector	25.37 / 243,762.23 GOOD
ROE Average (%) / Sector	25.25 / 48,758.47 GREAT
ROE Change Average (%) / Sector	-162.35 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

登録情報

Analyze Date	2026-08-05 07:59:51
Symbol	ATRA
Name	ATARA BIOTHERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	9.01 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	77.04 / 9,586.08

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1280 Rancho Conejo Blvd, Thousand Oaks, CA, United States, 91320

Phone: 805 623 4211

Website: https://www.atarabio.com

Sector: Healthcare >> Biotechnology

Description: Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.